J 2008

Common variable immunodeficiency disorders: division into distinct clinical phenotypes

CHAPEL, H., M. LUCAS, M. LEE, J. BJORKANDER, D. WEBSTER et. al.

Základní údaje

Originální název

Common variable immunodeficiency disorders: division into distinct clinical phenotypes

Název česky

Běžná variabilní imunodeficience: rozdělení odlišných fenotypů

Autoři

CHAPEL, H., M. LUCAS, M. LEE, J. BJORKANDER, D. WEBSTER, B. GRIMBACHER, C. FIESCHI, Vojtěch THON, MR. ABEDI a L. HAMMARSTROM

Vydání

Blood, 2008, 0006-4971

Další údaje

Jazyk

angličtina

Typ výsledku

Článek v odborném periodiku

Obor

30102 Immunology

Stát vydavatele

Spojené státy

Utajení

není předmětem státního či obchodního tajemství

Impakt faktor

Impact factor: 10.432

Organizační jednotka

Lékařská fakulta

UT WoS

000257696300016

Klíčová slova česky

imunodeficience; běžná variabilní imunodeficience

Klíčová slova anglicky

DISEASES CLASSIFICATION COMMITTEE; ANTIBODY DEFICIENCY; IMMUNE DEFICIENCY; B CELL; PRIMARY HYPOGAMMAGLOBULINEMIA; IMMUNOLOGICAL FEATURES; INTERNATIONAL UNION; T CELL; MANIFESTATIONS; COMPLICATIONS

Příznaky

Mezinárodní význam, Recenzováno
Změněno: 18. 6. 2009 12:11, prof. MUDr. Vojtěch Thon, Ph.D.

Anotace

V originále

The European Common Variable Immunodeficiency Disorders registry was started in 1996 to define distinct clinical phenotypes and determine overlap within individual patients. A total of 7 centers contributed patient data, resulting in the largest cohort yet reported. Patients (334), validated for the diagnosis, were followed for an average of 25.6 years (9461 patientyears). Data were used to define 5 distinct clinical phenotypes: no complications, autoimmunity, polyclonal lymphocytic infiltration, enteropathy, and lymphoid ma-lignancy. A total of 83% of patients had only one of these phenotypes. Analysis of mortality showed a considerable reduction in the last 15 years and that different phenotypes were associated with different survival times. Types of complications and clinical phenotypes varied significantly between countries, indicating the need for large, international registries. Ages at onset of symptoms and diagnosis were shown to have a Gaussian distribution, but were not useful predictors of phenotype. The only clinical predictor was polyclonal lymphocytic infiltration, which was associated with a 5-fold increased risk of lymphoid malignancy. There was widespread variation in the levels of serum immunoglobulin isotypes as well as in the percentages and absolute numbers of B cells, confirming the heterogeneity of these conditions. Higher serum IgM and lower circulating CD8 proportions were found to be predictive markers for polyclonal lymphocytic infiltration and autoimmunity, respectively.

Česky

Běžná variabilní imunodeficience: rozdělení odlišných fenotypů

Návaznosti

NR9035, projekt VaV
Název: Specifická protilátková odpověď u pacientů s poruchami imunity